Cargando…

Genetic tests obtainable through pharmacies: the good, the bad, and the ugly

Genomic medicine seeks to exploit an individual’s genomic information in the context of guiding the clinical decision-making process. In the post-genomic era, a range of novel molecular genetic testing methodologies have emerged, allowing the genetic testing industry to grow at a very rapid pace. As...

Descripción completa

Detalles Bibliográficos
Autores principales: Patrinos, George P, Baker, Darrol J, Al-Mulla, Fahd, Vasiliou, Vasilis, Cooper, David N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711749/
https://www.ncbi.nlm.nih.gov/pubmed/23835256
http://dx.doi.org/10.1186/1479-7364-7-17
_version_ 1782276966216368128
author Patrinos, George P
Baker, Darrol J
Al-Mulla, Fahd
Vasiliou, Vasilis
Cooper, David N
author_facet Patrinos, George P
Baker, Darrol J
Al-Mulla, Fahd
Vasiliou, Vasilis
Cooper, David N
author_sort Patrinos, George P
collection PubMed
description Genomic medicine seeks to exploit an individual’s genomic information in the context of guiding the clinical decision-making process. In the post-genomic era, a range of novel molecular genetic testing methodologies have emerged, allowing the genetic testing industry to grow at a very rapid pace. As a consequence, a considerable number of different private diagnostic testing laboratories now provide a wide variety of genetic testing services, often employing a direct-to-consumer (DTC) business model to identify mutations underlying (or associated with) common Mendelian disorders, to individualize drug response, to attempt to determine an individual’s risk of a multitude of complex (multifactorial) diseases, or even to determine a person’s identity. Recently, we have noted a novel trend in the provision of private molecular genetic testing services, namely saliva and buccal swab collection kits (for deoxyribonucleic acid (DNA) isolation) being offered for sale over the counter by pharmacies. This situation is somewhat different from the standard DTC genetic testing model, since pharmacists are healthcare professionals who are supposedly qualified to give appropriate advice to their clients. There are, however, a number of issues to be addressed in relation to the marketing of DNA collection kits for genetic testing through pharmacies, namely a requirement for regulatory clearance, the comparative lack of appropriate genetics education of the healthcare professionals involved, and most importantly, the lack of awareness on the part of both the patients and the general public with respect to the potential benefits or otherwise of the various types of genetic test offered, which may result in confusion as to which test could be beneficial in their own particular case. We believe that some form of genetic counseling should ideally be integrated into, and made inseparable from, the genetic testing process, while pharmacists should be obliged to receive some basic training about the genetic tests that they offer for sale.
format Online
Article
Text
id pubmed-3711749
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37117492013-07-17 Genetic tests obtainable through pharmacies: the good, the bad, and the ugly Patrinos, George P Baker, Darrol J Al-Mulla, Fahd Vasiliou, Vasilis Cooper, David N Hum Genomics Opinion Article Genomic medicine seeks to exploit an individual’s genomic information in the context of guiding the clinical decision-making process. In the post-genomic era, a range of novel molecular genetic testing methodologies have emerged, allowing the genetic testing industry to grow at a very rapid pace. As a consequence, a considerable number of different private diagnostic testing laboratories now provide a wide variety of genetic testing services, often employing a direct-to-consumer (DTC) business model to identify mutations underlying (or associated with) common Mendelian disorders, to individualize drug response, to attempt to determine an individual’s risk of a multitude of complex (multifactorial) diseases, or even to determine a person’s identity. Recently, we have noted a novel trend in the provision of private molecular genetic testing services, namely saliva and buccal swab collection kits (for deoxyribonucleic acid (DNA) isolation) being offered for sale over the counter by pharmacies. This situation is somewhat different from the standard DTC genetic testing model, since pharmacists are healthcare professionals who are supposedly qualified to give appropriate advice to their clients. There are, however, a number of issues to be addressed in relation to the marketing of DNA collection kits for genetic testing through pharmacies, namely a requirement for regulatory clearance, the comparative lack of appropriate genetics education of the healthcare professionals involved, and most importantly, the lack of awareness on the part of both the patients and the general public with respect to the potential benefits or otherwise of the various types of genetic test offered, which may result in confusion as to which test could be beneficial in their own particular case. We believe that some form of genetic counseling should ideally be integrated into, and made inseparable from, the genetic testing process, while pharmacists should be obliged to receive some basic training about the genetic tests that they offer for sale. BioMed Central 2013-07-08 /pmc/articles/PMC3711749/ /pubmed/23835256 http://dx.doi.org/10.1186/1479-7364-7-17 Text en Copyright © 2013 Patrinos et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Opinion Article
Patrinos, George P
Baker, Darrol J
Al-Mulla, Fahd
Vasiliou, Vasilis
Cooper, David N
Genetic tests obtainable through pharmacies: the good, the bad, and the ugly
title Genetic tests obtainable through pharmacies: the good, the bad, and the ugly
title_full Genetic tests obtainable through pharmacies: the good, the bad, and the ugly
title_fullStr Genetic tests obtainable through pharmacies: the good, the bad, and the ugly
title_full_unstemmed Genetic tests obtainable through pharmacies: the good, the bad, and the ugly
title_short Genetic tests obtainable through pharmacies: the good, the bad, and the ugly
title_sort genetic tests obtainable through pharmacies: the good, the bad, and the ugly
topic Opinion Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711749/
https://www.ncbi.nlm.nih.gov/pubmed/23835256
http://dx.doi.org/10.1186/1479-7364-7-17
work_keys_str_mv AT patrinosgeorgep genetictestsobtainablethroughpharmaciesthegoodthebadandtheugly
AT bakerdarrolj genetictestsobtainablethroughpharmaciesthegoodthebadandtheugly
AT almullafahd genetictestsobtainablethroughpharmaciesthegoodthebadandtheugly
AT vasiliouvasilis genetictestsobtainablethroughpharmaciesthegoodthebadandtheugly
AT cooperdavidn genetictestsobtainablethroughpharmaciesthegoodthebadandtheugly